Floatz logo

ETOPOSIDE

Gastrointestinal Cancers

Tianjin First Central HospitalSmall moleculePhase 1Active
CC
46/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
89/ 100

Competitive context

7 Active assets in the Gastrointestinal Cancers cohort.

Asset / SponsorPhaseRating
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Brian Anderson, MD
Phase 4BB
FAPI74
SOFIE
Phase 2B
Igf-Methotrexate Conjugate
IGF Oncology, LLC
Phase 1CC
VITAMIN D
Dana-Farber Cancer Institute
Phase 1CC
Adebrelimab
Tianjin First Central Hospital
D

View all 10 →

Same molecule, other indications

ETOPOSIDE is also rated in:

acute megakaryoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
acute monocytic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
acute myeloblastic leukemia with maturationDormant
BBB
Indicative ·
79 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →